Investor profile
Keyhaven Capital Partners
See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
Keyhaven Capital Partners is an independent London-based private equity firm exclusively focused on the European lower mid-market since 2003. The firm has developed a unique investment strategy, accessing private companies in partnership with best-in-class local sponsors or on its own, providing flexible and creative solutions for capital needs — including primary co-investments, direct secondaries, and continuation vehicles. Since inception, Keyhaven has invested or advised on investments worth in excess of €2.2 billion, representing over 65 transactions across Europe. Keyhaven's core strength lies in its ability to think independently, often as a first mover with a team or strategy. The firm targets businesses with enterprise values typically below €100 million, where deal flow is relationship-driven rather than auction-led. A central pillar of the approach is alignment: Keyhaven seeks transactions where management and sponsor partners have significant skin in the game, ensuring shared incentives and attractive entry pricing. The team of 23 professionals hails from 16 countries and speaks 20 languages, enabling deep local market access across the continent.
Notable quotes
“In the lower mid-market, there's always good deals going around that aren't intermediated and are under the radar of mainstream private equity. The cheques aren't as big, so the deals are easier to do.”
“The biggest thing for us is alignment. In all these deals, no matter what the transaction type, whether it's a new deal that we're co-underwriting together or a continuation solution or vehicle, there'll always be significant rollover from management or commitment from our sponsor partner.”
“Our proprietary sourcing approach and close partnerships with independent sponsors across the European lower mid-market enable us to uncover opportunities that are often overlooked.”
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| SRG Associati | PE | — | 2024 |
| Dent&Co | PE | — | 2024-03 |
| Novation Tech S.p.A. | PE | — | 2024 |
| Surexport | PE | — | 2023-10 |
| VONQ | PE | — | 2022 |
| Steer Automotive Group | PE | — | 2022-06 |
| Real Good Dental | PE | — | 2021-07 |
| HTBA (HealthTech Bio Actives) | PE | — | — |
| Proclinic Group | PE | — | — |
| Darag Group | PE | — | 2013 |
Frequent co-investors
| VC firm | Deals together |
|---|---|
| Alantra Private Equity | 2 |
| Chiltern Capital | 1 |
| TriSpan | 1 |
| Oquendo Capital | 1 |
| Adelis Equity Partners | 1 |
Fit check
Is Keyhaven Capital Partners a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit